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Abstract
Background: Due to a significant decline in the costs associated with next-generation sequencing, it has become
possible to decipher the genetic architecture of a population by sequencing a large number of individuals to a
deep coverage. The Korean Personal Genomes Project (KPGP) recently sequenced 35 Korean genomes at high
coverage using the Illumina Hiseq platform and made the deep sequencing data publicly available, providing the
scientific community opportunities to decipher the genetic architecture of the Korean population.
Methods: In this study, we used two single nucleotide variant (SNV) calling pipelines: mapping the raw reads
obtained from whole genome sequencing of 35 Korean individuals in KPGP using BWA and SOAP2 followed by
SNV calling using SAMtools and SOAPsnp, respectively. The consensus SNVs obtained from the two SNV pipelines
were used to represent the SNVs of the Korean population. We compared these SNVs to those from 17 other
populations provided by the HapMap consortium and the 1000 Genomes Project (1KGP) and identified SNVs that
were only present in the Korean population. We studied the mutation spectrum and analyzed the genes of non-
synonymous SNVs only detected in the Korean population.
Results: We detected a total of 8,555,726 SNVs in the 35 Korean individuals and identified 1,213,613 SNVs detected
in at least one Korean individual (SNV-1) and 12,640 in all of 35 Korean individuals (SNV-35) but not in 17 other
populations. In contrast with the SNVs common to other populations in HapMap and 1KGP, the Korean only SNVs
had high percentages of non-silent variants, emphasizing the unique roles of these Korean only SNVs in the Korean
population. Specifically, we identified 8,361 non-synonymous Korean only SNVs, of which 58 SNVs existed in all 35
Korean individuals. The 5,754 genes of non-synonymous Korean only SNVs were highly enriched in some metabolic
pathways. We found adhesion is the top disease term associated with SNV-1 and Nelson syndrome is the only
disease term associated with SNV-35. We found that a significant number of Korean only SNVs are in genes that
are associated with the drug term of adenosine.
Conclusion: We identified the SNVs that were found in the Korean population but not seen in other populations,
and explored the corresponding genes and pathways as well as the associated disease terms and drug terms. The
results expand our knowledge of the genetic architecture of the Korean population, which will benefit the
implementation of personalized medicine for the Korean population.
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Introduction
Genetics is the key to deciphering the phenotypic diversity
of different populations. Given that it is impossible for two
individuals to have exactly identical genomes, even a
monozygotic twin pair, decoding sequence information
becomes the first and most important step in searching
for genetic factors leading to phenotypic diversity. Since
the 3 billion base pairs of the human genome were pub-
lished in 2003 [1,2], many types of genetic studies have
been conducted [3,4].
Taking advantage of microarrays, genome-wide associa-
tion studies (GWAS) have been utilized to identify com-
mon variants associated with different phenotypes among
populations [5-7]. Next generation sequencing (NGS)
enables us to identify not only common variants but also
rare variants at a relatively low cost [8-15]. Many studies
have already used whole genome sequencing to explore
the whole spectrum of the genomic variation in both
healthy individuals [16,17] and individuals associated with
clinical indications [18-20], aiming at uncovering the com-
plexities of the genome and possible clinical associations.
The HapMap Project [21] and the 1000 Genomes Project
(1KGP) [22] are two large efforts at deciphering the var-
iants in various populations by microarray and NGS,
respectively. More than 38 million variants were identified
from 1,887 normal samples of 17 populations by HapMap
[23,24] and 1KGP [25,26], providing comprehensive refer-
ences of variants for genetic studies.
The Korean population is an Asian population not
included in HapMap or 1KGP. The first study decoding
the Korean genome was published in 2009 [27]. There-
after, several publications further revealed the genetic var-
iation within the Korean population [28,29]. GeVab [30]
(http://gevab.org/) is a genome browser integrating all the
variants (including 3.44 million SNPs) identified from the
first Korean genome. However, to our knowledge, no com-
prehensive genetic architecture for the Korean population
has been constructed to decipher the unique Korean
population genetic features.
Here, we aimed at utilizing whole genome sequencing
data to characterize the genetic features of the Korean
population. Through comparative analyses with genetic
variants detected by HapMap and 1KGP, we identified
the SNVs only contained in the Korean population and
explored their associations with functional pathways,
disease terms and drug terms. The findings deepen our
understanding of the genetics and evolution of the Kor-
ean population and are expected to facilitate persona-
lized medicine for the Korean population.
Materials and methods
Study design and workflow
The raw reads of whole genome sequencing of 35 Korean
individuals were analyzed by two SNV calling pipelines.
One used BWA [31] for mapping reads and SAMtools
[32] for SNV calling; the other used SOAP2 [33] for map-
ping reads and SOAPsnp [34] for SNV calling. For each
of the two pipelines, SNVs for each of the 35 Korean
individuals were identified. The SNVs from the 35 indivi-
duals were merged together according to their genomic
positions separately for the two pipelines. The SNVs
were then compared between pipelines. Only those SNVs
detected by both pipelines in the 35 individuals were con-
sidered to have relatively high quality and termed as Kor-
ean SNVs for the subsequent analyses. The remaining
SNVs were detected by only one pipeline and deemed to
be of low quality and not used in subsequent analysis.
Next, we compared the Korean SNVs with the SNVs
detected from other populations in 1KGP and HapMap
and divided the Korean SNVs into two types: the SNVs
detected in at least one of the 35 Korean individuals but
not identified in other populations in HapMap and 1KGP
(termed as SNV-1) and the SNVs detected in both Kor-
ean population and other populations (termed as shared
SNVs). Both shared SNVs and Korean only SNVs were
then annotated separately. According to the annotations,
non-synonymous SNVs in Korean only SNVs were deter-
mined and then the involved genes were identified to
perform gene ontology and KEGG pathway enrichment
analyses and to explore their associations with diseases
and drugs. The workflow is shown in Figure 1.
Source of data
The whole genome sequencing data from the Korean
Personal Genome Project (KPGP) (http://opengenome.
net/index.php/Main_Page) are publicly available and can
be downloaded from http://opengenome.net/index.php/
Korean. We obtained the data via the Critical Assess-
ment of Massive Data Analysis (CAMDA) consortium
(http://dokuwiki.bioinf.jku.at/doku.php/start). The data
contained whole genome sequencing raw reads, BWA
alignment results, and SAMtools SNV-calling results.
The raw reads were generated from an Illumina Hiseq
system using paired-end sequencing with 90 base pairs
(bp) read length. There were 38 samples, which included
one Caucasian female and her two children. The
remaining 35 samples were of Korean descent and used
in this study. In addition, we downloaded the SNVs (in
hg19 format) of nine Korean individuals from TIARA
(http://tiara.gmi.ac.kr/download) that were detected
from whole genome sequencing data [28].
Alignment
Two sets of alignment results were generated for the raw
reads of the 35 Korean samples. The first set was provided
by KPGP and was generated by using BWA (version 0.5.9)
to map raw reads to the human genome (hg19) with 45bp
seed sequence allowed (see Additional file 1 for details).
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The second set of alignment results was generated in our
laboratory, using SOAPaligner/SOAP2 (version 2.21) and
mapped the raw reads to the human genome reference
(ftp://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/
chromFaMasked.tar.gz) (hg19) with no indels and at most
five mismatches allowed (see Additional file 1 for details).
SNV calling
Two different SNV calling pipelines were run against the
two sets of alignment results to call SNVs in each indivi-
dual. The first set of SNV calling results were generated by
KPGP based on their alignment results from BWA. The
SNVs were called using mpileup command of SAMtools
(version 0.1.16) with depth ≥5 (termed as SAMtools SNVs
for simplicity) (see Additional file 1 for details). The sec-
ond SNV calling pipeline using SOAPsnp (version 1.05)
was applied by our laboratory. SNVs from this pipeline
were termed as SOAPsnp SNVs (see Additional file 1 for
details). In this pipeline, duplicated reads were removed
from the raw reads alignment of SOAP2 and the resultant
aligned reads were used for SNV calling by SOAPsnp with
options: -r 0.0005 -e 0.001 -t -u -L 90 -Q i. Next, filters of
quality score (≥20), neighbor distance (≥5) and depth (≥3)
were applied to the SNV calling results.
Comparing SNVs between two pipelines
The SNVs of all 35 samples were combined to generate a
merged SNVs file for each pipeline. If a SNV was not
detected in a sample, then we assigned the reference allele
to that sample at that location. The merged SNV files
were compared between pipelines according to genomic
positions of SNVs. The SNVs with overlapped genomic
Figure 1 Study design and workflow of this study. The whole genome sequencing data of 35 individuals were used for mapping to the
human genome and SNV calling by two pipelines. The overlapped SNVs from the two pipelines were used to represent Korean population and
then compared with two references to search for Korean only SNVs and shared SNVs with other populations. Then shared SNVs were annotated.
For the Korean only SNVs, two subgroups (SNV-1 and SNV-35) were derived in accordance with the occurrences in the Korean population. The
two subgroups of SNVs were then annotated. The non-synonymous SNVs were determined and the corresponding genes were used for
enrichment and association analyses.
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positions between the two files were deemed to be of rela-
tively high confidence and were named as Korean SNVs
for subsequent analyses. The genotypes for each Korean
SNV were determined based on the results from SOAPsnp.
Preprocessing raw genotype files from HapMap and 1KGP
The genotypes of 1,092 individuals in 1KGP were
downloaded from ftp://ftp.1000genomes.ebi.ac.uk/vol1/
ftp/phase1/analysis_results/integrated_call_sets/. SNVs
were extracted from the raw genotype files with the
requirement of “VT=SNP” in the “INFO” column for
23 chromosomes (autosome chromosomes and X chro-
mosome) and no requirement for Y chromosome. The
Perl program is included in Additional file 1.
The genotypes of 1,417 individuals from HapMap
were downloaded from ftp://ftp.ncbi.nlm.nih.gov/hap-
map/genotypes/2010-08_phaseII+III/ (Feb 12, 2013).
First, raw genotype files from different populations were
merged together to generate a consensus genotype file.
The 424 locations that were indels or had non-unique
rsIDs were removed from the consensus genotype file.
Since HapMap provided SNP positions based on human
genome hg18 version, while SNV positions of 1KGP
and our results were based on hg19 version, we con-
verted the positions of HapMap SNVs from hg18 ver-
sion to hg19 version using liftOver [35]. The SNVs that
failed to be converted were then compared with 1KGP.
If a SNV had the same rsID in 1KGP and HapMap,
then the hg19 position of this SNV in 1KGP was
assigned to the SNV in HapMap. The reference allele of
each SNV was determined by searching the sequence of
hg18 human genome (downloaded from ftp://ftp.ncbi.
nih.gov/genomes/H_sapiens/ARCHIVE/BUILD.36.3/
Assembled_chromosomes/, on March 22, 2013).
Determining shared SNVs and Korean only SNVs
Among Korean SNVs, 1KGP and HapMap, 134 SNVs were
found to have at least two rsIDs. We required that one
SNV have only one rsID, and therefore randomly selected
one rsID for such SNVs and discarded the remaining lines
of such SNVs from the three genotype files.
Next, we compared the SNVs from the three datasets
according to their hg19 positions. If the same SNV was
included in both Korean SNVs and 1KGP (or in both
Korean SNVs and HapMap), then the SNV was categor-
ized as a shared SNV, otherwise the SNV was categor-
ized as a Korean only SNV.
Determination of occurrences in population of SNVs
The occurrence of each SNV in a population was defined
as the number of samples that contained the SNV in the
population. For the Korean only SNVs, we used SNV-i to
present the set of SNVs with occurrences ≥ i.
SNP annotation
We used VEP [36] (release 75) to annotate the SNVs. The
file “homo_sapiens_vep_75.tar.gz” (ftp://ftp.ensembl.org/
pub/release-75/variation/VEP/homo_sapiens_vep_75.tar.
gz) was used as the reference file for annotation. The
detailed source list for the reference file can be found at
http://useast.ensembl.org/info/genome/variation/sources_-
documentation.html#homo_sapiens. Specifically, in
this version of the reference file, the gene symbols origi-
nated from RFAM, Uniprot_gn, miRBase, HGNC,
Clone_based_vega_gene, and Clone_based_ensembl_gene.
The non-synonymous SNVs were defined as the SNVs




variant” and “splice_region_variant” in the “Consequence”
column of VEP annotation results. We thereafter named
the non-synonymous SNVs in SNV-i as SNV-i/ns.
Calculating SNV count per gene
For each of the four SNV sets (SNV-1, SNV-35, SNV-1/ns,
and SNV-35/ns), all of the involved genes were used to
study the number of identified SNVs found in each gene.
We then ranked the genes according to their SNV counts.
Functional enrichment analyses
Gene ontology and KEGG pathway enrichment analyses
were conducted for genes of SNV-i/ns using WebGestalt
[37,38]. Associations of the SNV-i/ns involved genes with
disease terms and drug terms were identified using Web-
Gestalt, which were actually based on the predictions from
GLAD4U (http://bioinfo.vanderbilt.edu/glad4u/). The
GLAD4U algorithm first queries all the disease (drug)
terms from PharmGKB in the MEDLINE database to
retrieve the corresponding publications, next determines
the gene-to-publication link according to Entrez Gene
information, and finally returns the genes significantly
associated with the query disease (drug) terms. The asso-
ciated references of WebGestalt included Gene Ontology
(version 1.2, 11/11/2012), KEGG (03/21/2011), PharmGKB
(1/26/2013) and GLAD4U (1/26/2013). The hypergeo-
metric test was used for enrichment evaluation analysis.
Multiple test adjustment was performed using the BH
(Benjamini & Hochberg) method [39] (https://stat.ethz.ch/
R-manual/R-devel/library/stats/html/p.adjust.html).
Results and discussions
Read alignment and SNV calling
A total of 3.8 TB raw whole genome sequencing data from
35 Korean samples was acquired from KPGP, with depth
in each sample ranging from 30X to 42X (mean = 36X)
(Additional file 2). Using the aligner BWA, KPGP mapped
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93.41% of raw reads to the human reference genome
(Additional file 2). Based on the alignment results, KPGP
then identified an average of 3,421,868 SNVs in each indi-
vidual using SAMtools (Additional file 2). Merging all the
identified SNVs in each individual yielded a final set of
9,119,633 SAMtools SNVs.
In our pipeline, 91.01% of raw reads were mapped to the
human reference genome by SOAP2 (Additional file 2).
Using the mapped reads, SOAPsnp then identified an aver-
age of 3,395,688 SNVs in each individual (Additional file 2).
By merging all the SNVs identified in each individual, a
total of 9,964,511 SOAPsnp SNVs were identified.
Determining Korean SNVs
Given the still difficult task of detecting accurate SNVs
with a single calling tool, and that SNVs detected by mul-
tiple pipelines will likely have relatively higher accuracy
[40], we used the overlapped set of SNVs from the two
pipelines to represent the Korean population. After com-
paring SOAPsnp SNVs with SAMtools SNVs in terms of
genomic positions, we identified a total of 8,555,726 Kor-
ean SNVs, covering 85.86% of SOAPsnp SNVs and
93.82% of SAMtools SNVs. The SNV density was almost
uniform in each chromosome except sex chromosomes
(Additional file 3).
Comparing SNVs from different populations
We then compared the Korean SNVs with two public
references, 1KGP and HapMap, to search for Korean
only SNVs. We found that 2,677,812 (31.3%) Korean
SNVs were covered by both 1KGP and HapMap (Addi-
tional file 3); 10,791 (0.13%) Korean SNVs overlapped
HapMap SNV calls only, while 4,653,510 (54.39%) Korean
SNVs overlapped 1KGP only (Additional file 3). Finally,
we identified 1,213,613 Korean only SNVs (SNV-1) after
the comparison, representing 12.18% of the Korean
SNVs. From the SNV-1, 12,640 SNVs with occurrences =
35 (SNV-35) were identified (Additional file 4).
Korean SNVs and Korean only SNVs frequency features
We computed the occurrence rate of Korean SNVs and
Korean only SNVs among the 35 individuals with results
plotted in Figures 2a and 2b, respectively. The plots show
the percent of SNVs versus the number of the 35 indivi-
duals sharing the SNVs. Figure 2a shows that nearly 20 %
of Korean SNVs are observed in only one individual. We
deemed the singular SNVs occurrences to be of lower
confidence and reliability, as they are most likely to be
attributable to errors in sequencing, reference genome or
analyses. Similarly, confidence and reliability of SNVs
likely increases as prevalence of an individual SNV
increases in the 35 individuals. Nearly 7% (571,571) of
SNVs occur in all 35 individuals. Between 1.5% and
somewhat more than 2% of SNVs are prevalent in 10 to
34 individuals. Figure 2b shows that nearly 60.59 %
(735,271) of Korean only SNVs are observed in only one
individual, while 1.04% (12,640) of Korean only SNVs are
observed in all 35 individuals. Therefore, we rationally
conjectured that Korean only SNVs prevalent across
many of the individuals would be more important for
treating Koreans differently from other populations in
the personalized medicine.
SNV frequency in different populations
For each of the 7,331,322 SNVs detected in both the
Korean population and 1KGP, we calculated its fre-
quency for the Korean population and for each of the
14 populations included in 1KGP. The frequency distri-
butions of the 15 populations are plotted in Additional
file 5. For SNVs with frequency larger than 0.2, the dis-
tributions are very similar, while the distributions of
SNVs having frequency less than 0.2 are relatively differ-
ent. The results suggested that low frequency SNVs can
better characterize populations than high frequency
SNVs.
Assessing reproducibility of Korean only SNVs
Ju et al. [28] conducted whole genome sequencing of 10
Korean individuals at 26.1-fold coverage and identified
3.45 to 3.73 million SNVs from each individual by align-
ing reads to the human genome reference hg18. We
downloaded the SNVs from 9 individuals that were con-
verted to hg19 by the authors and used those SNVs to
assess reproducibility of the Korean only SNVs detected
in this study. We detected 3,318,098 to 3,444,114
(SOAPsnp) and 3,369,094 to 3,480,518 (SAMtools)
SNVs from each of the 35 Koreans (Additional file 2),
similar to Ju’s result. We further assessed reproducibility
of the Korean only SNVs by identifying the Korean only
SNVs contained in the SNVs from Ju et al [28]. Addi-
tional file 4 lists the reproducibility values for SNV-i,
revealing that the SNVs detected in more samples are
more reproducible.
Substitution mutational spectrum in the Korean
population
We evaluated the mutation spectrum on both the Kor-
ean SNVs and Korean only SNVs (SNV-1 and SNV-35).
For Korean SNVs, the transition/transversion ratio was
2.1 (Additional file 6), the same as the expected ratio for
the human genome calculated using whole genome
sequencing data [41]. According to the SNV composi-
tions (Figure 3), we found that the most prevalent
changes in all three SNV sets was C:G->T:A transition,
the same trend as the raw base substitution mutational
spectrum in humans [42]. In addition, we found that
Korean SNVs and SNV-1 occurred more frequently at
C/G base pairs, which was consistent with previous
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Figure 2 Frequency distribution of Korean SNVs and Korean only SNVs. Frequency distributions in terms of occurrences in the population
were calculated and plotted for Korean SNVs (a) and Korean only SNVs (b). The x-axis indicates the occurrences and the y-axis gives the
corresponding SNV frequency in %.
Zhang et al. BMC Bioinformatics 2014, 15(Suppl 11):S6
http://www.biomedcentral.com/1471-2105/15/S11/S6
Page 6 of 13
findings [42]. Nevertheless, almost half of SNV-35 muta-
tions occurred at T/A base pairs.
SNVs with potential functional consequences
One of the major objectives of this study was finding
Korean only SNVs with potential functional conse-
quences that differentiated the Korean population from
other populations. To this end, we annotated all the Kor-
ean SNVs by separating them into different groups,
including (1) Korean only SNVs (SNV-1), (2) Korean only
SNVs (SNV-35), (3) shared SNVs between Korean SNVs
and 1KGP, (4) shared SNVs among Korean SNVs, 1KGP
and HapMap, and (5) shared SNVs between Korean SNVs
and 1KGP or between Korean SNVs and HapMap. We
Figure 3 Mutation spectrum of Korean SNVs. The base substitution types of SNVs in the: (a) Korean SNVs, (b) Korean only SNVs (SNV-1) and
(c) Korean only SNVs (SNV-35) are on the y-axis, and SNV number for category is on x-axis. Percentages in the parentheses give proportion
among all SNVs. SNVs with multiple alternative alleles were considered to be SNVs with uncertain mutation type.
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found that the majority (89.46%) of Korean SNVs came
from introns followed by intergenic regions (Figure 4 and
Table 1). The total SNVs located in these two regions
were 87.79% for SNV-1, 83.35% for SNV-35, 90.02% for
SNVs among Korean SNVs, 1KGP and HapMap, 89.74%
for SNVs shared between Korean SNVs and 1KGP, and
89.73% for SNVs shared between Korean SNVs and 1KGP
or between Korean SNVs and HapMap. In addition, we
found noncoding transcript SNVs to be third most
prevalent.
Although the majority of the SNVs belonged to the
top three ranked categories, we still found many SNVs
that would alter the amino acid code (Table 1): 12,185
in SNV-1, 88 in SNV-35, 32,805 in shared SNVs among
Korean SNVs, 1KGP and HapMap, 62,677 in shared
SNVs between Korean SNVs and 1KGP, and 62,820 in
shared SNVs between Korean SNVs and 1KGP or
between Korean SNVs and HapMap. Interestingly, of
these, 70.56%, 67.04%, 57.39%, 58.54%, 58.56% were
non-synonymous SNVs, respectively in the categories,
which would change the amino acid code and therefore
alter the protein (Table 1). These results indicated that,
although SNVs shared by Korean, 1KGP and HapMap
have similar distributions of SNV categories within CDS
and splicing regions, the Korean only SNVs (SNV-1 and
SNV-35) have higher percentages of total non-synonymous
SNVs than shared SNVs in these two regions; this implied
a potential importance of these non-synonymous SNVs in
differentiating Korean from other populations.
Korean only SNVs gene enrichment
We studied the number of SNVs per gene for Korean
only SNVs. A total of 53,771 genes were covered by
1,213,613 Korean only SNVs (SNV-1), some of which
had an especially high number of Korean only SNVs, e.g.
PRIM2 (5,033 SNVs) (Figure 5a,Additional file 7). When
considering the 12,640 SNVs of SNV-35, we also found a
total of 1,640 genes involved and PRIM2 had an extre-
mely high number of SNVs (1,470 SNVs) (Figure 5b
andAdditional file 7). In addition, we evaluated the num-
ber of SNVs per gene in the non-synonymous SNVs
(8,361 for SNV-1/ns and 58 for SNV-35/ns). Some 5,754
(10.7% of 53,771) genes were found to be involved
in SNV-1/ns and 37 (2.3% of 1,640) in SNV-35/ns
(Additional file 7). As shown in Figures 5c and 5d,
MUC4 (116) and OR4C5 (11) had enriched non-synon-
ymous SNVs from SNV-1 and SNV-35, respectively.
Gene ontology analysis of non-synonymous Korean only
SNVs
We clustered genes associated with non-synonymous
SNVs in SNV-1 and SNV-35 in order to search for GO
term enrichment. We found the most enriched GO terms
were motor activity (p-value with multiple test adjustment
(adjP) = 6.40e-12) for non-synonymous SNV-1 and system
process (adjP= 0.0150) for non-synonymous SNV-35
(Additional file 8).
Non-synonymous Korean only SNVs pathway analysis
We analyzed pathway enrichment using genes associated
with non-synonymous SNVs in SNV-1 and SNV-35. We
found metabolic pathway (adjP = 2.61e-37) was the top
enriched pathway in non-synonymous SNVs in SNV-1,
followed by ECM-receptor interaction (adjP = 7.90e-20)
(Additional file 9). For SNV-35, we found that requiring
at least two genes be observed in the pathway resulted
in only three pathways hits, vibrio cholera infection
(adjP = 0.0018), axon guidance (adjP = 0.0051) and
olfactory transduction (adjP = 0.0279) (Additional file 9).
Non-synonymous Korean only SNVs disease association
analyses
We analyzed disease association by WebGestalt using the
genes involved in non-synonymous SNVs in SNV-1 and
SNV-35. Briefly, we searched the genes for associations
with disease terms of PharmGKB. We found adhesion
(adjP = 3.44e-59), disease susceptibility (adjP = 1.21e-36)
and genetic predisposition to disease (adjP = 5.23e-35)
were the most prevalent disease terms associated with
SNV-1/ns (Table 2 and Additional file 10). Nelson syn-
drome (adjP = 0.0102) was associated with SNV-35/ns.
Therefore, we inferred that special attention should be
made for the Korean population when treated for the
above mentioned terms related diseases, since other popu-
lations did not carry those Korean only SNVs. To assess
robustness of the significantly associated disease terms
identified, we conducted the same association analysis for
SNV-i, i = 2 to 10. The top 10 significantly associated dis-
ease terms as well as their corresponding multiple text
adjusted p-values are listed in Additional file 11. Close
analysis of the significantly associated disease terms
revealed that the terms are stable with an average 55% of
terms sharing by two SNV-i (i = 2 to 10) and the larger
the i value, and the smaller the difference between two
i values, the more terms are shared (Additional file 12).
Non-synonymous Korean only SNVs drug association
analyses
Using WebGestalt, we identified associations with drugs
for the genes involved in non-synonymous SNVs in SNV-
1 and SNV-35. Similar to the disease association analysis,
we searched the drug terms of PharmGKB for associa-
tions. Results showed adenosine (adjP = 1.24e-18) to be
the drug term most associated with SNV-1/ns, followed by
adenosine triphosphate (adjP = 2.61e-13), and immune
globulin (adjP = 2.88e-13) (Table 3 and Additional file 11).
We found mennitol (adjP = 0.0001), niflumic acid (adjP =
0.0001) and adenosine monophosphate (adjP = 0.0022) are
Zhang et al. BMC Bioinformatics 2014, 15(Suppl 11):S6
http://www.biomedcentral.com/1471-2105/15/S11/S6
Page 8 of 13
the most associated drug terms for SNV-35/ns (Table 3
and Additional file 13). Based on our analysis, we hypothe-
size that Koreans might have different responses to the
above mentioned terms-related drugs, when compared to
other populations. More follow-up studies are required to
confirm our findings.
Conclusions
This study characterized the SNVs of 35 Korean indivi-
duals through comparing them with SNVs from 17 other
populations. Many Asian populations have been sequenced
in past years, contributing ever more to deciphering the
specific features of variants in each population. Our work
adds more valuable insights toward a more thorough char-
acterization of Korean variants. We identified a total of
1,213,613 Korean only SNVs, 12,640 of which occurred in
all of the 35 samples. The mutation spectrum of Korean
SNVs was in accordance with expectations [42]. Some
10.58% of Korean SNVs were located in exonic regions
(Table 1). SNV-1 had 8,361 non-synonymous variants and
their involved genes were found enriched in some meta-
bolic pathways. SNV-35 contained 58 non-synonymous
variants. Enrichment analysis also found adhesion to be the
disease term most associated with SNV-1, while Nelson
syndrome was the only disease term associated with the
SNV-35. Also, we found that Korean only SNVs were in
Figure 4 Annotation of Korean SNVs. Annotation using VEP [36], of different group: SNVs-1 (the red bars), SNV-35 (the purple bars), shared
SNVs between Korean SNVs and 1KGP or between Korean SNVs and HapMap (the cyan bars), shared SNVs between Korean SNVs and 1KGP (the
dark purple bars), shared SNV between Korean SNVs, 1KGP and HapMap (the dark yellow bars). The x-axis gives number of SNVs in log2
transformation and y-axis gives the annotation terms.
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genes most associated with the drug term adenosine. Alto-
gether, this study should expand our knowledge of the
genetic variants in the Korean population, contributing to
the development of personalized medicine for this
population.
Disclosure
The findings and conclusions in this article have not
been formally disseminated by the US Food and Drug
Administration (FDA) and should not be construed to
represent the FDA determination or policy.
Table 1 Annotations of Korean only SNVs and shared SNVs
Category SNV-11 (%) SNV-
352 (%)




Shared with 1KGP or
HapMap (%)
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Total SNVs 1,213,613 12,640 2,677,812 7,331,322 7,342,113
1SNV-1: SNVs with occurrences ≥ 1 in all of 35 samples.
2SNV-35: SNVs with occurrences = 35 in all of 35 samples.
3CDS: coding DNA sequence
4UTR: untranslated region
5NMD: Nonsense Mediated decay
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Figure 5 Distribution of count of Korean SNVs per gene. The count of SNVs per gene was calculated for SNVs in SNV-1 (a), SNV-35 (b), SNV-
1/ns (c) and SNV-35/ns (d). Top one or two ranked genes were labeled. The x-axis indicates SNVs per gene in log10 transformation and the y-
axis depicts number of genes.
Table 2 Top associated disease terms with non-synonymous SNVs in SNV-1 and SNV-35.
Korean only
SNVs
Order Disease term Gene
count






SNV-1/ns 1 Adhesion 241 37.249 2.28E-62 3.44E-59
2 Disease Susceptibility 238 28.848 1.60E-39 1.21E-36
3 Genetic Predisposition to Disease 231 28.589 1.04E-37 5.23E-35
4 Myocardial Infarction 90 37.190 4.95E-24 1.87E-21
5 Urologic Diseases 98 34.386 4.48E-23 1.13E-20
6 Subarachnoid Hemorrhage 54 51.923 4.30E-23 1.13E-20
7 Metabolic Diseases 162 26.471 6.55E-23 1.41E-20
8 Kidney Diseases 95 34.672 1.04E-22 1.74E-20
9 Skin and Connective Tissue
Diseases
137 28.482 1.04E-22 1.74E-20
10 Nervous System Diseases 176 25.360 1.48E-22 2.23E-20
SNV-35/ns 1 Nelson syndrome 3 0.446 0.0102 0.0102
Table 3 Top associated drug terms with non-synonymous SNVs in SNV-1 and SNV-35.
Korean only SNVs Order Drug term Gene count %of all genes in the category P value (raw) P value (adjusted)
SNV-1/ns 1 adenosine 133 27.883 3.47E-21 1.24E-18
2 adenosine triphosphate 87 29.097 1.46E-15 2.61E-13
3 immune globulin 145 23.237 2.42E-15 2.88E-13
4 hydroxyurea 30 46.154 9.01E-12 8.04E-10
5 glutathione 84 24.633 7.75E-11 4.61E-09
6 phosphoric acid 50 31.447 6.76E-11 4.61E-09
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Additional material
Additional file 1: Supplementary Methods.
Additional file 2: Supplementary Table S1 Basic statistics of raw
reads and results of read mapping and SNV calling using two
pipelines.
Additional file 3: Supplementary Table S2 Number of Korean SNVs
and Korean only SNVs in each category.
Additional file 4: Supplementary Table S3 A list of SNV number per
chromosome as well as SNV density per chromosome.
Additional file 5: Supplementary Figure S1 SNV frequency
distributions in 15 populations. Frequency distributions in terms of
occurrences in the populations were calculated for the SNVs detected in
both Korean and the 14 populations from 1KGP. Populations: KOR (35
Koreans in our study), ASW (people with African ancestry in Southwest
United States), CEU (Utah residents with ancestry from Northern and
Western Europe), CHB (Han Chinese in Beijing, China), CHS (Han Chinese
South, China), CLM (Colombians in Medellin, Colombia), FIN (Finnish in
Finland), GBR (British from England and Scotland, UK), IBS (Iberian
populations in Spain), JPT (Japanese in Tokyo, Japan), LWK (Luhya in
Webuye, Kenya), MXL (people with Mexican ancestry in Los Angeles,
California), PUR (Puerto Ricans in Puerto Rico), TSI (Toscani in Italia), and
YRI (Yoruba in Ibadan, Nigeria).
Additional file 6: Supplementary Table S4 A list of numbers of
transition SNVs and transversion SNVs per sample.
Additional file 7: Supplementary Table S5 A list of genes involved
in Korean SNVs (SNV-1, SNV-35, SNV-1/ns and SNV-35/ns) and the
SNV count per gene.
Additional file 8: Supplementary Table S6 Detailed information of
top GO terms enriched in non-synonymous Korean only SNVs (SNV-
1/ns and SNV-35/ns).
Additional file 9: Supplementary Table S7 Detailed information of
top pathways enriched in non-synonymous Korean only SNVs (SNV-
1/ns and SNV-35/ns).
Additional file 10: Supplementary Table S8 Detailed information of
top disease terms associated with non-synonymous Korean only
SNVs (SNV-1/ns and SNV-35/ns).
Additional file 11: Supplementary Table S9 Detailed information of
top disease terms associated with non-synonymous Korean only
SNVs (SNV-2/ns to SNV-10/ns).
Additional file 12: Supplementary Table S10 Shared top 10 disease
terms associated with non-synonymous Korean only SNVs (SNV-2/
ns to SNV-10/ns).
Additional file 13: Supplementary Table S11 Detailed information of
top drug terms associated with non-synonymous Korean only SNVs
(SNV-1/ns and SNV-35/ns).
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